These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8233008)

  • 1. [The viable myocardium: metabolic, diagnostic and therapeutic aspects].
    Strozzi C; Spisani P
    Minerva Cardioangiol; 1993; 41(7-8):279-86. PubMed ID: 8233008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hibernating myocardium: a review.
    Heusch G; Schulz R
    J Mol Cell Cardiol; 1996 Dec; 28(12):2359-72. PubMed ID: 9004153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology of the "hibernating" myocardium].
    Schulz R; Heusch G
    Z Kardiol; 1995; 84 Suppl 4():91-100. PubMed ID: 8585279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversible left ventricular dysfunction in coronary disease (part one): myocardial stunning].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(1-2):39-44. PubMed ID: 10953549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible myocardial dysfunction: basics and evaluation.
    Gowda RM; Khan IA; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Dec; 97(3):349-53. PubMed ID: 15561318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hibernation and stunning as manifestations of ischemic dysfunction of the myocardium].
    Sokolova RI; Zhdanov VS
    Arkh Patol; 2002; 64(1):50-4. PubMed ID: 11889704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversible dysfunction of myocardial contraction].
    Mates M; Veselka J
    Vnitr Lek; 1998 Oct; 44(10):598-605. PubMed ID: 10422494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hibernating myocardium.
    Brown TA
    Am J Crit Care; 2001 Mar; 10(2):84-91; quiz 92-3. PubMed ID: 11244676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of cell survival in myocardial hibernation.
    Depre C; Vatner SF
    Trends Cardiovasc Med; 2005 Apr; 15(3):101-10. PubMed ID: 16039970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hibernating myocardium in heart failure.
    Bhatia G; Sosin M; Leahy JF; Connolly DL; Davis RC; Lip GY
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):111-22. PubMed ID: 15723580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hibernating myocardium, stunning, ischemic preconditioning: clinical relevance.
    Futterman LG; Lemberg L
    Am J Crit Care; 2000 Nov; 9(6):430-6. PubMed ID: 11072559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic ischaemic ('hibernating') and postischaemic ('stunned') dysfunctional but viable myocardium.
    Trevi GP; Sheiban I
    Eur Heart J; 1991 Dec; 12 Suppl G():20-6. PubMed ID: 1806375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation of nonrevascularized human hibernating and chronically stunned myocardium to long-term chronic myocardial ischemia.
    Wiggers H; Nielsen SS; Holdgaard P; Flø C; Nørrelund H; Halbirk M; Nielsen TT; Egeblad H; Rehling M; Bøtker HE
    Am J Cardiol; 2006 Dec; 98(12):1574-80. PubMed ID: 17145213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Down-regulation and hibernating myocardium].
    Schipke JD
    Z Kardiol; 1991 Dec; 80(12):703-11. PubMed ID: 1776321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The open artery hypothesis: beneficial effects and long-term prognostic importance of patency of the infarct-related coronary artery.
    Centurión OA
    Angiology; 2007; 58(1):34-44. PubMed ID: 17351156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hibernating myocardium: pathophysiology, diagnosis, and treatment.
    Slezak J; Tribulova N; Okruhlicova L; Dhingra R; Bajaj A; Freed D; Singal P
    Can J Physiol Pharmacol; 2009 Apr; 87(4):252-65. PubMed ID: 19370079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural evidence of increased tolerance of hibernating myocardium to cardioplegic ischemia-reperfusion injury.
    Milei J; Fraga CG; Grana DR; Ferreira R; Ambrosio G
    J Am Coll Cardiol; 2004 Jun; 43(12):2329-36. PubMed ID: 15193702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.